Brind.

Cosmos Health Inc. Reports Record Direct-to-Consumer Sales in U.S.

1 report, 1 independent Updated Oct 13
AI-generated briefing. Brind wrote this from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Cosmos Health Inc. reported that its United States direct-to-consumer sales reached a record of more than $92,000 on October 11, 2026. Sales totaled $902,000 over the past 30 days, and the average daily sales over the past 10 days exceeded $60,000, which is double the 30-day average. The company is currently evaluating extending this sales model to additional brands and markets.

From itemonline.com

Why it matters

Some supportBrind's analysis of the reports

The current 10-day sales pace, if maintained, corresponds to approximately $21.9 million in annualized U.S. revenue, nearing the over $23 million annual projection previously set by the company. This acceleration suggests strong market demand for the company's products.

From itemonline.com

Who's involved

  • CosmParent company of the legal entity reporting the sales.
  • companyLegal entity that reported the record direct-to-consumer sales.

Who could feel it

Possible knock-on effects

These are possibilities Brind reasoned out, not predictions, and not advice. Most are not stated in any report.

  • NasdaqSpeculative

    The stock listed on Nasdaq might see its financial performance positively impacted by the record sales.

Possible ripples

Who this could reach next, traced step by step from the reporting. Possibilities worth considering, not forecasts.

Keep exploring

The entities involved

Coverage

Newest first; wire copies grouped